|
G |
Actn1 |
actinin, alpha 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ACTN1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions increases expression |
ISO |
Linuron binds to and results in increased activity of AHR protein; SIGMAR1 gene promotes the reaction [Linuron results in increased expression of AHR mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of AHR mRNA] |
CTD |
PMID:18835618 PMID:30661753 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
EXP |
Linuron results in increased expression of APAF1 mRNA |
CTD |
PMID:28705778 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Ar |
androgen receptor |
multiple interactions decreases activity increases expression decreases expression affects binding affects activity |
ISO EXP |
Dihydrotestosterone inhibits the reaction [Linuron results in increased activity of AR protein]; Linuron binds to and results in decreased activity of AR protein; Linuron inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Linuron inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; Linuron inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; Linuron inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; Linuron inhibits the reaction [Metribolone binds to AR protein]; Linuron inhibits the reaction [Metribolone results in increased activity of AR protein]; Linuron inhibits the reaction [Stanozolol binds to and results in increased activity of AR protein]; Linuron inhibits the reaction [Testosterone results in increased activity of AR protein]; methoxyacetic acid inhibits the reaction [Linuron inhibits the reaction [Testosterone results in increased activity of AR protein]] Linuron results in decreased activity of AR protein Linuron results in increased expression of AR mRNA Linuron binds to and results in decreased activity of AR protein; Linuron inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; Linuron inhibits the reaction [Metribolone binds to AR protein] Linuron results in decreased expression of AR mRNA Linuron binds to AR protein Linuron affects the activity of AR protein |
CTD |
PMID:10910998 PMID:10964759 PMID:11861974 PMID:12730624 PMID:14565775 PMID:14687758 PMID:15064155 PMID:18315717 PMID:18324785 PMID:18486176 PMID:19833195 PMID:20438827 PMID:21251949 PMID:21310686 PMID:26867867 PMID:29162470 PMID:33049310 More...
|
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arg1 |
arginase 1 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of ARG1 mRNA SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of ARG1 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of ARG1 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
XBP1 gene promotes the reaction [Linuron results in increased expression of ARNT mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Avp |
arginine vasopressin |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of AVP mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
|
|
G |
Bace1 |
beta-secretase 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
|
|
G |
Bace2 |
beta-secretase 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr11:36,707,447...36,789,550
Ensembl chr11:36,707,458...36,789,546
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
EXP |
Linuron results in increased expression of BAX mRNA |
CTD |
PMID:36410587 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
increases expression |
EXP |
Linuron results in increased expression of BECN1 mRNA |
CTD |
PMID:28705778 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
decreases expression |
EXP |
Linuron results in decreased expression of BMP4 mRNA |
CTD |
PMID:12730624 |
|
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Bmpr1b |
bone morphogenetic protein receptor type 1B |
decreases expression |
EXP |
Linuron results in decreased expression of BMPR1B mRNA |
CTD |
PMID:12730624 |
|
NCBI chr 2:230,538,252...230,871,077
Ensembl chr 2:230,541,558...230,871,368
|
|
G |
Bsn |
bassoon (presynaptic cytomatrix protein) |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BSN mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 8:108,784,849...108,875,819
Ensembl chr 8:108,788,542...108,875,819
|
|
G |
Cacna1a |
calcium voltage-gated channel subunit alpha1 A |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1A mRNA |
CTD |
PMID:25607892 |
|
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
|
|
G |
Cacna1b |
calcium voltage-gated channel subunit alpha1 B |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1B mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091
|
|
G |
Cacna1c |
calcium voltage-gated channel subunit alpha1 C |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
|
|
G |
Cacna1d |
calcium voltage-gated channel subunit alpha1 D |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1D mRNA |
CTD |
PMID:25607892 |
|
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA |
CTD |
PMID:25607892 |
|
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Cacna1i |
calcium voltage-gated channel subunit alpha1 I |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNA1I mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688
|
|
G |
Cacna2d3 |
calcium voltage-gated channel auxiliary subunit alpha2delta 3 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CACNA2D3 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr16:4,098,439...4,912,498
Ensembl chr16:4,098,445...4,912,351
|
|
G |
Cacnb1 |
calcium voltage-gated channel auxiliary subunit beta 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr10:82,998,182...83,018,838
Ensembl chr10:82,998,182...83,018,694
|
|
G |
Cacnb3 |
calcium voltage-gated channel auxiliary subunit beta 3 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB3 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 7:129,784,799...129,797,074
Ensembl chr 7:129,783,674...129,797,074
|
|
G |
Cacng2 |
calcium voltage-gated channel auxiliary subunit gamma 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 7:109,572,838...109,698,516
Ensembl chr 7:109,574,459...109,697,227
|
|
G |
Cacng6 |
calcium voltage-gated channel auxiliary subunit gamma 6 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG6 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:65,732,910...65,747,377
Ensembl chr 1:65,732,632...65,747,341
|
|
G |
Cacng7 |
calcium voltage-gated channel auxiliary subunit gamma 7 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNG7 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:65,800,059...65,831,246
Ensembl chr 1:65,800,355...65,831,006
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CADM1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA |
CTD |
PMID:25607892 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CAMK2G mRNA |
CTD |
PMID:25607892 |
|
NCBI chr15:3,504,017...3,563,050
Ensembl chr15:3,504,085...3,563,050
|
|
G |
Cartpt |
CART prepropeptide |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in increased expression of CARTPT mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713
|
|
G |
Casp3 |
caspase 3 |
increases expression |
EXP |
Linuron results in increased expression of CASP3 mRNA |
CTD |
PMID:28705778 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of CCL1 mRNA SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL1 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL1 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
multiple interactions increases expression |
ISO |
SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL17 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of CCL2 mRNA 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA]]; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL2 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of CCL20 mRNA SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL20 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL20 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of CCL4 mRNA SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL4 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
multiple interactions increases expression |
ISO |
SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCR2 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCR2 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Cd44 |
CD44 molecule |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd81 |
Cd81 molecule |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CD81 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
EXP |
Linuron results in decreased expression of CDK2 mRNA |
CTD |
PMID:28705778 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
EXP |
Linuron results in increased expression of CDKN1A mRNA |
CTD |
PMID:28705778 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Chga |
chromogranin A |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CHGA mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398
|
|
G |
Cntf |
ciliary neurotrophic factor |
multiple interactions increases expression |
ISO |
XBP1 gene promotes the reaction [Linuron results in increased expression of CNTF mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 1:209,887,854...209,889,877
Ensembl chr 1:209,887,854...209,889,877
|
|
G |
Cox7a2 |
cytochrome c oxidase subunit 7A2 |
increases expression |
EXP |
Linuron results in increased expression of COX7A2 mRNA |
CTD |
PMID:28705778 |
|
NCBI chr 8:80,716,824...80,720,922
Ensembl chr14:51,301,168...51,301,633 Ensembl chr 8:51,301,168...51,301,633
|
|
G |
Crh |
corticotropin releasing hormone |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] affects the expression of CRH mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Csf2 |
colony stimulating factor 2 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of CSF2 mRNA 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of CSF2 mRNA]]; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of CSF2 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CSF2 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CSF2 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
multiple interactions increases expression |
ISO |
SIGMAR1 gene promotes the reaction [Linuron results in increased expression of CSPG4 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of CSPG4 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of CXCL10 mRNA SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CXCL10 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of CXCL12 mRNA XBP1 gene promotes the reaction [Linuron results in increased expression of CXCL12 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Linuron results in decreased expression of CYP11A1 mRNA; Linuron results in decreased expression of CYP11A1 protein |
CTD |
PMID:28007637 PMID:28705778 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Linuron results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:28007637 PMID:28705778 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity |
EXP |
Linuron results in increased activity of CYP1A1 protein |
CTD |
PMID:7823289 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases response to substance |
ISO |
CYP1A2 protein results in decreased susceptibility to Linuron |
CTD |
PMID:29573710 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of CYP1B1 mRNA XBP1 gene promotes the reaction [Linuron results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:16040568 PMID:30661753 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
affects activity |
EXP |
Linuron affects the activity of CYP2B1 protein |
CTD |
PMID:7823289 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
affects activity |
EXP |
Linuron affects the activity of CYP2B2 protein |
CTD |
PMID:7823289 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[Chlorfenvinphos co-treated with ethion co-treated with Linuron] results in increased expression of CYP3A4 mRNA |
CTD |
PMID:25028461 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Dcc |
DCC netrin 1 receptor |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DCC mRNA |
CTD |
PMID:25607892 |
|
NCBI chr18:64,868,987...65,972,783
Ensembl chr18:64,873,898...65,972,740
|
|
G |
Ddx4 |
DEAD-box helicase 4 |
increases expression |
EXP |
Linuron results in increased expression of DDX4 mRNA |
CTD |
PMID:36410587 |
|
NCBI chr 2:44,227,946...44,282,867
Ensembl chr 2:44,227,946...44,282,723
|
|
G |
Dlg1 |
discs large MAGUK scaffold protein 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DLG1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr11:68,911,883...69,103,230
Ensembl chr11:68,911,883...69,102,689
|
|
G |
Dlg4 |
discs large MAGUK scaffold protein 4 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of DLG4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLG4 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
|
|
G |
Dlgap3 |
DLG associated protein 3 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP3 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 5:139,491,972...139,562,625
Ensembl chr 5:139,492,947...139,562,625
|
|
G |
Dlgap4 |
DLG associated protein 4 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP4 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:145,124,189...145,271,791
Ensembl chr 3:145,175,479...145,270,490
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
increases expression |
EXP |
Linuron results in increased expression of DLL1 mRNA |
CTD |
PMID:12730624 |
|
NCBI chr 1:56,312,062...56,320,177
Ensembl chr 1:56,312,066...56,320,179
|
|
G |
Dnm1 |
dynamin 1 |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of DNM1 mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 3:15,604,782...15,648,654
Ensembl chr 3:15,604,784...15,648,538
|
|
G |
Doc2a |
double C2 domain alpha |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DOC2A mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:181,457,415...181,462,528
Ensembl chr 1:181,458,390...181,462,030
|
|
G |
Dpp10 |
dipeptidyl peptidase like 10 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr13:34,584,420...36,269,292
Ensembl chr13:34,595,868...36,269,292
|
|
G |
Dpp6 |
dipeptidyl peptidase like 6 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DPP6 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 4:7,589,386...8,508,666
Ensembl chr 4:7,591,009...8,508,532
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPYD mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression multiple interactions |
EXP |
Linuron results in decreased expression of EGFR mRNA [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGFR mRNA |
CTD |
PMID:12730624 PMID:25607892 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
decreases expression |
EXP |
Linuron results in decreased expression of EIF4E mRNA |
CTD |
PMID:28705778 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of ENTPD1 mRNA SIGMAR1 gene promotes the reaction [Linuron results in increased expression of ENTPD1 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of ENTPD1 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB3 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB4 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
increases activity multiple interactions |
ISO |
Linuron results in increased activity of ERN1 protein 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of ERN1 protein modified form]] Linuron promotes the reaction [ERN1 protein binds to SIGMAR1 protein] |
CTD |
PMID:30661753 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO EXP |
Linuron binds to and results in increased activity of ESR1 protein [Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of ESR1 mRNA |
CTD |
PMID:33049310 PMID:34383603 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
Linuron binds to and results in increased activity of ESR2 protein |
CTD |
PMID:33049310 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
decreases expression |
EXP |
Linuron results in decreased expression of FGFR2 mRNA |
CTD |
PMID:12730624 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FMR1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
|
|
G |
Fshr |
follicle stimulating hormone receptor |
decreases expression |
EXP |
Linuron results in decreased expression of FSHR mRNA |
CTD |
PMID:36410587 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FYN mRNA |
CTD |
PMID:25607892 |
|
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
|
|
G |
Gabra4 |
gamma-aminobutyric acid type A receptor subunit alpha 4 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRA4 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr14:36,590,782...36,667,724
Ensembl chr14:36,590,782...36,665,844
|
|
G |
Gabrb1 |
gamma-aminobutyric acid type A receptor subunit beta1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRB1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr14:36,068,725...36,548,946
Ensembl chr14:36,080,393...36,548,948
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GDNF mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gls |
glutaminase |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
|
|
G |
Gpc1 |
glypican 1 |
decreases expression |
EXP |
Linuron results in decreased expression of GPC1 mRNA |
CTD |
PMID:12730624 |
|
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
|
|
G |
Gria4 |
glutamate ionotropic receptor AMPA type subunit 4 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA4 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 8:1,562,118...2,035,035
Ensembl chr 8:1,562,119...2,034,979
|
|
G |
Grid2 |
glutamate ionotropic receptor delta type subunit 2 |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of GRID2 mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 4:92,415,019...93,892,472
Ensembl chr 4:92,415,230...93,889,355
|
|
G |
Grik1 |
glutamate ionotropic receptor kainate type subunit 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIK1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr11:27,169,739...27,571,131
Ensembl chr11:27,169,740...27,570,645
|
|
G |
Grik2 |
glutamate ionotropic receptor kainate type subunit 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIK2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN2B mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Grin2d |
glutamate ionotropic receptor NMDA type subunit 2D |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of GRIN2D mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 1:96,306,871...96,346,994
Ensembl chr 1:96,308,365...96,344,793
|
|
G |
Grip1 |
glutamate receptor interacting protein 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIP1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 7:54,934,856...55,592,274
Ensembl chr 7:54,934,250...55,592,273
|
|
G |
Hbg1 |
hemoglobin subunit gamma 1 |
decreases expression |
EXP |
Linuron results in decreased expression of HBG1 mRNA |
CTD |
PMID:16498641 |
|
NCBI chr 1:158,271,871...158,273,426
Ensembl chr 1:158,271,873...158,273,425
|
|
G |
Hes6 |
hes family bHLH transcription factor 6 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of HES6 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 9:92,001,849...92,003,562
Ensembl chr 9:92,001,841...92,003,559
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of HIF1A mRNA XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of HIF1A mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
decreases expression |
EXP |
Linuron results in decreased expression of HSD17B3 mRNA |
CTD |
PMID:28007637 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression |
EXP |
Linuron results in decreased expression of HSD3B1 mRNA |
CTD |
PMID:36410587 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
EXP |
Linuron results in decreased expression of IDI1 mRNA |
CTD |
PMID:16498641 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ifnar1 |
interferon alpha and beta receptor subunit 1 |
multiple interactions increases expression |
ISO |
SIGMAR1 gene promotes the reaction [Linuron results in increased expression of IFNAR1 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of IFNAR1 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr11:30,725,774...30,752,227
Ensembl chr11:30,725,790...30,749,979
|
|
G |
Ifnb1 |
interferon beta 1 |
multiple interactions increases expression |
ISO |
SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of IFNB1 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Ifng |
interferon gamma |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of IFNG mRNA SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of IFNG mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IFNG mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
increases expression |
EXP |
Linuron results in increased expression of IGF1 mRNA |
CTD |
PMID:12730624 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
decreases expression |
EXP |
Linuron results in decreased expression of IGF1R mRNA |
CTD |
PMID:12730624 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of IGF2R mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
decreases expression |
EXP |
Linuron results in decreased expression of IGFBP5 mRNA |
CTD |
PMID:12730624 |
|
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
|
|
G |
Il10 |
interleukin 10 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of IL10 mRNA XBP1 gene promotes the reaction [Linuron results in increased expression of IL10 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il10ra |
interleukin 10 receptor subunit alpha |
multiple interactions increases expression |
ISO |
SIGMAR1 gene promotes the reaction [Linuron results in increased expression of IL10RA mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
|
|
G |
Il13 |
interleukin 13 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of IL13 mRNA XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL13 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
ISO |
1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of RELA protein modified form]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of XBP1 protein modified form]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased splicing of XBP1 mRNA]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA]]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of CSF2 mRNA]]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of ERN1 protein modified form]]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of IL6 mRNA]]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]]; [IL1B protein co-treated with TNF protein co-treated with Linuron] promotes the reaction [XBP1 protein binds to NOS2 promoter]; [IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of RELA protein modified form; [IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of XBP1 protein modified form; [IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased splicing of XBP1 mRNA; [IL1B protein co-treated with TNF protein] results in increased susceptibility to Linuron; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA]; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of CSF2 mRNA]; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of IL6 mRNA]; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL1B mRNA]; STF 083010 inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL1B mRNA] 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]]; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]; STF 083010 inhibits the reaction [[Linuron co-treated with IL1B protein co-treated with TNF protein] results in increased splicing of XBP1 mRNA]; STF 083010 inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]] |
CTD |
PMID:30661753 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of IL1RAPL1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr X:51,371,969...52,876,726
Ensembl chr X:51,378,215...52,876,772
|
|
G |
Il21 |
interleukin 21 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of IL21 mRNA SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL21 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 2:120,117,105...120,127,012
Ensembl chr 2:120,119,444...120,126,996
|
|
G |
Il23a |
interleukin 23 subunit alpha |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of IL23A mRNA SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL23A mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL23A mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
|
|
G |
Il5 |
interleukin 5 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of IL5 mRNA XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL5 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO |
1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of IL6 mRNA]]; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of IL6 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL6 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL6 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Inha |
inhibin subunit alpha |
decreases expression |
EXP |
Linuron results in decreased expression of INHA mRNA |
CTD |
PMID:36410587 |
|
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
|
|
G |
Inhba |
inhibin subunit beta A |
decreases expression |
EXP |
Linuron results in decreased expression of INHBA mRNA |
CTD |
PMID:36410587 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Irf3 |
interferon regulatory factor 3 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of IRF3 mRNA XBP1 gene promotes the reaction [Linuron results in increased expression of IRF3 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935
|
|
G |
Irf7 |
interferon regulatory factor 7 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of IRF7 mRNA XBP1 gene promotes the reaction [Linuron results in increased expression of IRF7 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Irf9 |
interferon regulatory factor 9 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of IRF9 mRNA XBP1 gene promotes the reaction [Linuron results in increased expression of IRF9 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr15:29,095,474...29,101,924
Ensembl chr15:29,095,789...29,101,236
|
|
G |
Kiss1 |
KiSS-1 metastasis-suppressor |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of KISS1 mRNA |
CTD |
PMID:34383603 |
|
NCBI chr13:44,775,106...44,780,707
Ensembl chr13:44,774,823...44,780,612
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
decreases expression increases secretion |
ISO |
Linuron results in decreased expression of KLK3 mRNA Linuron results in increased secretion of KLK3 protein |
CTD |
PMID:20363314 PMID:33932781 |
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
decreases expression |
EXP |
Linuron results in decreased expression of LHCGR mRNA |
CTD |
PMID:36410587 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of LIF mRNA SIGMAR1 gene promotes the reaction [Linuron results in increased expression of LIF mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of LIF mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Lrrc7 |
leucine rich repeat containing 7 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of LRRC7 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:247,146,616...247,634,945
Ensembl chr 2:247,147,752...247,634,547
|
|
G |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MAGI2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 4:14,386,389...15,870,036
Ensembl chr 4:14,386,399...15,870,240
|
|
G |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MDGA2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 6:84,746,422...85,608,640
Ensembl chr 6:84,761,941...85,608,126
|
|
G |
Mfn2 |
mitofusin 2 |
decreases expression |
EXP |
Linuron results in decreased expression of MFN2 mRNA |
CTD |
PMID:28705778 |
|
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of MMP12 mRNA SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of MMP12 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of MMP12 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
|
|
G |
Msmb |
microseminoprotein, beta |
decreases expression |
ISO |
Linuron results in decreased expression of MSMB mRNA |
CTD |
PMID:33932781 |
|
NCBI chr16:7,366,536...7,387,124
Ensembl chr16:7,366,536...7,387,123
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
EXP |
Linuron results in decreased expression of MYC mRNA |
CTD |
PMID:28705778 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myom2 |
myomesin 2 |
increases expression |
EXP |
Linuron results in increased expression of MYOM2 mRNA |
CTD |
PMID:16498641 |
|
NCBI chr16:74,520,148...74,592,658
Ensembl chr16:74,520,157...74,592,772
|
|
G |
Nf1 |
neurofibromin 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NF1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr10:64,306,027...64,539,112
Ensembl chr10:64,306,301...64,536,658
|
|
G |
Nlgn1 |
neuroligin 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NLGN1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:108,256,236...109,181,530
Ensembl chr 2:108,257,824...109,002,464
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of NOS2 mRNA 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]]; [IL1B protein co-treated with TNF protein co-treated with Linuron] promotes the reaction [XBP1 protein binds to NOS2 promoter]; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of NOS2 mRNA]; STF 083010 inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of NOS2 mRNA] 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]]; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]; STF 083010 inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]] |
CTD |
PMID:30661753 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch2 |
notch receptor 2 |
decreases expression multiple interactions |
EXP |
Linuron results in decreased expression of NOTCH2 mRNA [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of NOTCH2 mRNA |
CTD |
PMID:12730624 PMID:25607892 |
|
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
|
|
G |
Notch3 |
notch receptor 3 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NOTCH3 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025
|
|
G |
Notch4 |
notch receptor 4 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOTCH4 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr20:4,160,362...4,184,466
Ensembl chr20:4,160,445...4,184,465
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
Linuron binds to and results in increased activity of NR1I2 protein [Chlorfenvinphos co-treated with ethion co-treated with Linuron] results in increased activity of NR1I2 protein; Linuron binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:21115097 PMID:25028461 PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of NR3C1 mRNA |
CTD |
PMID:34383603 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nrcam |
neuronal cell adhesion molecule |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRCAM mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 6:61,402,813...61,698,536
Ensembl chr 6:61,329,863...61,702,992
|
|
G |
Nrg1 |
neuregulin 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Nrxn1 |
neurexin 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRXN1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 6:3,177,788...4,323,848
Ensembl chr 6:3,177,897...4,322,710
|
|
G |
Nrxn2 |
neurexin 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRXN2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:203,726,420...203,842,301
Ensembl chr 1:203,735,753...203,842,297
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NTRK2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Oxt |
oxytocin/neurophysin I prepropeptide |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of OXT mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
EXP |
Linuron results in decreased expression of PCNA mRNA; Linuron results in decreased expression of PCNA protein |
CTD |
PMID:28007637 PMID:28705778 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of PGR mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pomc |
proopiomelanocortin |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] affects the expression of POMC mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
Linuron binds to and results in increased activity of PPARG protein |
CTD |
PMID:33049310 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of PPP1R1B mRNA |
CTD |
PMID:34383603 |
|
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of PRKN mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[Linuron binds to and results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of and results in decreased secretion of Prostaglandin D2 |
CTD |
PMID:26359731 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of RELA protein modified form]; [IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of RELA protein modified form |
CTD |
PMID:30661753 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Reln |
reelin |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of RELN mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 4:12,736,177...13,162,956
Ensembl chr 4:12,736,130...13,162,211
|
|
G |
Robo1 |
roundabout guidance receptor 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ROBO1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr11:10,580,863...11,621,675
Ensembl chr11:10,580,908...11,620,203
|
|
G |
Rps6kb2 |
ribosomal protein S6 kinase B2 |
decreases expression |
EXP |
Linuron results in decreased expression of RPS6KB2 mRNA |
CTD |
PMID:28705778 |
|
NCBI chr 1:201,451,265...201,458,096
Ensembl chr 1:201,451,265...201,458,078
|
|
G |
Rptor |
regulatory associated protein of MTOR, complex 1 |
decreases expression |
EXP |
Linuron results in decreased expression of RPTOR mRNA |
CTD |
PMID:28705778 |
|
NCBI chr10:104,878,487...105,176,986
Ensembl chr10:104,878,487...105,176,983
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of RXRA mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SHANK2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:199,146,210...199,590,962
Ensembl chr 1:199,169,429...199,589,394
|
|
G |
Shbg |
sex hormone binding globulin |
decreases expression |
EXP |
Linuron results in decreased expression of SHBG mRNA |
CTD |
PMID:28705778 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
|
|
G |
Sigmar1 |
sigma non-opioid intracellular receptor 1 |
increases activity multiple interactions decreases response to substance |
ISO |
Linuron results in increased activity of SIGMAR1 protein Linuron promotes the reaction [ERN1 protein binds to SIGMAR1 protein] SIGMAR1 gene mutant form results in decreased susceptibility to Linuron SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of ARG1 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL1 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL17 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL20 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL4 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCR2 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CSF2 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CXCL10 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of IFNB1 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of IFNG mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL1B mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL21 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL23A mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL6 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of MMP12 mRNA]; SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of NOS2 mRNA]; SIGMAR1 gene promotes the reaction [Linuron results in increased expression of AHR mRNA]; SIGMAR1 gene promotes the reaction [Linuron results in increased expression of CSPG4 mRNA]; SIGMAR1 gene promotes the reaction [Linuron results in increased expression of ENTPD1 mRNA]; SIGMAR1 gene promotes the reaction [Linuron results in increased expression of IFNAR1 mRNA]; SIGMAR1 gene promotes the reaction [Linuron results in increased expression of IL10RA mRNA]; SIGMAR1 gene promotes the reaction [Linuron results in increased expression of LIF mRNA]; SIGMAR1 gene promotes the reaction [Linuron results in increased expression of TGFB2 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 5:56,904,155...56,907,012
Ensembl chr 5:56,904,159...56,907,017
|
|
G |
Slc1a2 |
solute carrier family 1 member 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
|
|
G |
Slc1a6 |
solute carrier family 1 member 6 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A6 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 7:10,841,836...10,870,424
Ensembl chr 7:10,841,837...10,870,449
|
|
G |
Slit1 |
slit guidance ligand 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLIT1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:240,409,559...240,558,127
Ensembl chr 1:240,409,561...240,558,127
|
|
G |
Sptbn2 |
spectrin, beta, non-erythrocytic 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SPTBN2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:202,002,970...202,045,343
Ensembl chr 1:202,002,970...202,044,283
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
decreases expression |
EXP |
Linuron results in decreased expression of SRD5A1 mRNA |
CTD |
PMID:28705778 |
|
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
decreases activity |
ISO |
Linuron results in decreased activity of SRD5A2 protein |
CTD |
PMID:17218080 |
|
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression |
EXP |
Linuron results in decreased expression of STAR mRNA |
CTD |
PMID:28705778 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Stmn2 |
stathmin 2 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STMN2 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 2:93,204,690...93,252,011
Ensembl chr 2:93,204,692...93,252,011
|
|
G |
Sts |
steroid sulfatase |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of STS mRNA |
CTD |
PMID:25607892 |
|
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
|
|
G |
Stxbp1 |
syntaxin binding protein 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STXBP1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 3:16,076,725...16,138,431
Ensembl chr 3:16,076,391...16,138,369
|
|
G |
Syngap1 |
synaptic Ras GTPase activating protein 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of SYNGAP1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr20:5,026,366...5,056,659
Ensembl chr20:5,026,364...5,056,672
|
|
G |
Syp |
synaptophysin |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of SYP mRNA |
CTD |
PMID:25607892 |
|
NCBI chr X:14,849,444...14,864,553
Ensembl chr X:14,849,444...14,864,745
|
|
G |
Tff1 |
trefoil factor 1 |
increases expression |
ISO |
Linuron results in increased expression of TFF1 mRNA |
CTD |
PMID:35307500 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of TGFB1 mRNA |
CTD |
PMID:25607892 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
multiple interactions increases expression |
ISO |
SIGMAR1 gene promotes the reaction [Linuron results in increased expression of TGFB2 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of TGFB2 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgfb3 |
transforming growth factor, beta 3 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of TGFB3 mRNA XBP1 gene promotes the reaction [Linuron results in increased expression of TGFB3 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
EXP |
[Plasticizers co-treated with Fungicides, Industrial co-treated with Linuron co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with Dichlorodiphenyl Dichloroethylene co-treated with butylparaben co-treated with Acetaminophen] results in decreased expression of TH mRNA |
CTD |
PMID:34383603 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thra |
thyroid hormone receptor alpha |
multiple interactions |
ISO |
Linuron binds to and results in increased activity of THRA protein |
CTD |
PMID:33049310 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
affects expression |
EXP |
Linuron affects the expression of TIMP3 mRNA |
CTD |
PMID:12730624 |
|
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
|
|
G |
Tlr5 |
toll-like receptor 5 |
increases expression multiple interactions |
ISO |
Linuron results in increased expression of TLR5 mRNA XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of TLR5 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr13:94,634,778...94,658,992
Ensembl chr13:94,634,801...94,657,738
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO |
1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]]; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]; STF 083010 inhibits the reaction [[Linuron co-treated with IL1B protein co-treated with TNF protein] results in increased splicing of XBP1 mRNA]; STF 083010 inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]] 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of RELA protein modified form]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of XBP1 protein modified form]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased splicing of XBP1 mRNA]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA]]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of CSF2 mRNA]]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of ERN1 protein modified form]]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of IL6 mRNA]]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]]; [IL1B protein co-treated with TNF protein co-treated with Linuron] promotes the reaction [XBP1 protein binds to NOS2 promoter]; [IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of RELA protein modified form; [IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of XBP1 protein modified form; [IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased splicing of XBP1 mRNA; [IL1B protein co-treated with TNF protein] results in increased susceptibility to Linuron; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA]; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of CSF2 mRNA]; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of IL6 mRNA]; Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]; STF 083010 inhibits the reaction [Linuron promotes the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of TNF mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tsc1 |
TSC complex subunit 1 |
increases expression |
EXP |
Linuron results in increased expression of TSC1 mRNA |
CTD |
PMID:28705778 |
|
NCBI chr 3:11,969,547...12,018,591
Ensembl chr 3:11,979,729...12,015,674
|
|
G |
Tsc2 |
TSC complex subunit 2 |
multiple interactions increases expression |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of TSC2 mRNA Linuron results in increased expression of TSC2 mRNA |
CTD |
PMID:25607892 PMID:28705778 |
|
NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
|
|
G |
Unc5b |
unc-5 netrin receptor B |
multiple interactions |
EXP |
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of UNC5B mRNA |
CTD |
PMID:25607892 |
|
NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537
|
|
G |
Xbp1 |
X-box binding protein 1 |
decreases response to substance increases activity multiple interactions |
ISO |
XBP1 gene mutant form results in decreased susceptibility to Linuron Linuron results in increased activity of XBP1 protein 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of XBP1 protein modified form]; 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased splicing of XBP1 mRNA]; [IL1B protein co-treated with TNF protein co-treated with Linuron] promotes the reaction [XBP1 protein binds to NOS2 promoter]; [IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased expression of XBP1 protein modified form; [IL1B protein co-treated with TNF protein co-treated with Linuron] results in increased splicing of XBP1 mRNA; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of ARG1 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL1 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL2 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCL20 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CCR2 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of CSF2 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of HIF1A mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IFNG mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL13 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL1B mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL23A mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL5 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of IL6 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of MMP12 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of NOS2 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of TLR5 mRNA]; XBP1 gene mutant form inhibits the reaction [Linuron results in increased expression of TNF mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of AHR mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of ARNT mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of CNTF mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of CSPG4 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of CXCL12 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of CYP1B1 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of ENTPD1 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of IFNAR1 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of IL10 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of IRF3 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of IRF7 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of IRF9 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of LIF mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of TGFB2 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of TGFB3 mRNA] STF 083010 inhibits the reaction [[Linuron co-treated with IL1B protein co-treated with TNF protein] results in increased splicing of XBP1 mRNA] |
CTD |
PMID:30661753 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|